Showing results (1231-1240 of 1,963) with videos related to
Sort By:
Pageof 197
Expert Opinion on Drug Discovery|September 7, 2016
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphomaFederica Barbieri, Adriana Bajetto, Stefano Thellung, et al.Expert Opinion on Drug Discovery|September 10, 2016
Centipede venoms as a source of drug leadsEivind A B Undheim, Ronald A Jenner, Glenn F KingExpert Opinion on Drug Discovery|April 21, 2018
Identification of glia phenotype modulators based on select glial function regulatory signaling pathwaysSun-Hwa Lee, Kyoungho SukExpert Opinion on Drug Discovery|July 13, 2017
Novel approaches to the design of bioavailable melanotropinsYang Zhou, Minying CaiExpert Opinion on Drug Discovery|September 28, 2016
The development of targeted new agents to improve the outcome for children with leukemiaFrancisco Bautista, Jasper Van der Lugt, Pamela R Kearns, et al.Expert Opinion on Drug Discovery|August 30, 2016
Innovation in non-Hodgkin lymphoma drug discovery: what needs to be done?Magdalena Witkowska, Piotr Smolewski, Agata Majchrzak, et al.Expert Opinion on Drug Discovery|May 13, 2017
Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug developmentBoris Kubuschok, Martin TrepelExpert Opinion on Drug Discovery|August 23, 2016
Fluorination methods for drug discovery and developmentPaul RichardsonExpert Opinion on Drug Discovery|April 18, 2018
Murine models of psoriasis and their usefulness for drug discoveryShih-Yi Chuang, Chih-Hung Lin, Calvin T Sung, et al.Expert Opinion on Drug Discovery|April 18, 2018
Computational modeling of human oral bioavailability: what will be next?Miguel Ángel Cabrera-Pérez, Hai Pham-ThePageof 197